TCM
Tekla Capital Management Portfolio holdings
AUM
$2.56B
1-Year Return
18.15%
This Quarter Return
+8.89%
1 Year Return
+18.15%
3 Year Return
+62.34%
5 Year Return
+140.22%
10 Year Return
+499.57%
AUM
$2.76B
AUM Growth
+$127M
(+4.8%)
Cap. Flow
-$167M
Cap. Flow
% of AUM
-6.04%
Top 10 Holdings %
Top 10 Hldgs %
47.95%
Holding
149
New
13
Increased
31
Reduced
25
Closed
14
Top Buys
| 1 |
AGN
Allergan plc
AGN
|
$28.7M |
| 2 |
Illumina
ILMN
|
$25.5M |
| 3 |
SHPG
Shire pic
SHPG
|
$25.1M |
| 4 |
MDVN
MEDIVATION, INC.
MDVN
|
$22.3M |
| 5 |
HCA Healthcare
HCA
|
$13.9M |
Top Sells
| 1 |
Viatris
VTRS
|
$81.3M |
| 2 |
Alkermes
ALKS
|
$52M |
| 3 |
AET
Aetna Inc
AET
|
$36.3M |
| 4 |
AKRX
Akorn, Inc.
AKRX
|
$26.3M |
| 5 |
MDRX
Veradigm Inc. Common Stock
MDRX
|
$24.7M |
Sector Composition
| 1 | Healthcare | 88.47% |
| 2 | Real Estate | 3.59% |
| 3 | Financials | 0% |
| 4 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALR
51
DELISTED
Alere Inc
ALR
| $11.6M | 0.42% |
297,901
| – | – |
|
52
Ardelyx
ARDX
$1.58B
| $11.6M | 0.42% |
639,370
-900
| -0.1% | -$16.3K |
|
53
Stryker
SYK
$151B
| $11.5M | 0.42% |
123,940
| – | – |
|
54
GSK
GSK
$79.8B
| $11.5M | 0.42% |
228,000
| – | – |
|
55
Zimmer Biomet
ZBH
$20.8B
| $10.5M | 0.38% |
105,369
| – | – |
|
|
LTC
56
LTC Properties
LTC
$1.68B
| $10.2M | 0.37% |
236,618
| – | – |
|
|
ITCI
57
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $10.1M | 0.37% |
187,800
+37,800
| +25% | +$2.03M |
|
|
DHC
58
Diversified Healthcare Trust
DHC
$939M
| $9.95M | 0.36% |
670,504
-6,035
| -0.9% | -$89.6K |
|
59
Ultragenyx Pharmaceutical
RARE
$3.01B
| $9.92M | 0.36% |
88,400
| – | – |
|
60
Idexx Laboratories
IDXX
$51.2B
| $9.65M | 0.35% |
132,352
| – | – |
|
61
Medtronic
MDT
$119B
| $9.57M | 0.35% |
124,344
-82,700
| -40% | -$6.36M |
|
62
Natera
NTRA
$22.9B
| $9.53M | 0.35% |
882,358
+68,058
| +8% | +$735K |
|
63
Sabra Healthcare REIT
SBRA
$4.58B
| $9.23M | 0.33% |
456,190
| – | – |
|
64
Icon
ICLR
$13.7B
| $8.93M | 0.32% |
114,900
+42,900
| +60% | +$3.33M |
|
|
PVLA
65
Palvella Therapeutics, Inc. Common Stock
PVLA
$599M
| $8.81M | 0.32% |
48,102
| – | – |
|
66
Universal Health Services
UHS
$11.8B
| $8.4M | 0.3% |
+70,300
| New | +$8.4M |
|
67
Community Health Systems
CYH
$398M
| $8.08M | 0.29% |
368,411
+114,829
| +45% | +$2.52M |
|
|
JUNO
68
DELISTED
Juno Therapeutics, Inc.
JUNO
| $8M | 0.29% |
182,000
| – | – |
|
69
Novartis
NVS
$249B
| $7.98M | 0.29% |
103,453
| – | – |
|
70
Centene
CNC
$14.1B
| $7.9M | 0.29% |
240,000
| – | – |
|
71
Eli Lilly
LLY
$666B
| $7.22M | 0.26% |
85,667
| – | – |
|
|
WCG
72
DELISTED
Wellcare Health Plans, Inc.
WCG
| $6.93M | 0.25% |
88,652
| – | – |
|
73
CytomX Therapeutics
CTMX
$346M
| $6.85M | 0.25% |
+328,059
| New | +$6.85M |
|
|
MACK
74
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $6.75M | 0.24% |
108,516
| – | – |
|
75
Dynavax Technologies
DVAX
$1.17B
| $6.64M | 0.24% |
275,000
| – | – |
|